Last reviewed · How we verify
YJ001 for Spray Use
YJ001 for Spray Use is a Small molecule drug developed by Yuejia Pharmaceuticals (USA), Inc.. It is currently in Phase 1 development. Also known as: YJ001.
At a glance
| Generic name | YJ001 for Spray Use |
|---|---|
| Also known as | YJ001 |
| Sponsor | Yuejia Pharmaceuticals (USA), Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP (PHASE1)
- Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YJ001 for Spray Use CI brief — competitive landscape report
- YJ001 for Spray Use updates RSS · CI watch RSS
- Yuejia Pharmaceuticals (USA), Inc. portfolio CI
Frequently asked questions about YJ001 for Spray Use
What is YJ001 for Spray Use?
YJ001 for Spray Use is a Small molecule drug developed by Yuejia Pharmaceuticals (USA), Inc..
Who makes YJ001 for Spray Use?
YJ001 for Spray Use is developed by Yuejia Pharmaceuticals (USA), Inc. (see full Yuejia Pharmaceuticals (USA), Inc. pipeline at /company/yuejia-pharmaceuticals-usa-inc).
Is YJ001 for Spray Use also known as anything else?
YJ001 for Spray Use is also known as YJ001.
What development phase is YJ001 for Spray Use in?
YJ001 for Spray Use is in Phase 1.
Related
- Manufacturer: Yuejia Pharmaceuticals (USA), Inc. — full pipeline
- Also known as: YJ001
- Compare: YJ001 for Spray Use vs similar drugs
- Pricing: YJ001 for Spray Use cost, discount & access